GSK updates total voting rights count
GSK plc reported its total voting rights as of 31 March 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
GSK plc reported its total voting rights as of 31 March 2026. The company had 4,316,179,781 issued ordinary shares of 31 ¼ pence each, with 256,112,615 shares held in treasury. This leaves 4,060,067,166 voting rights, which shareholders can use as the denominator for disclosure threshold calculations under UK transparency rules.
Key Figures
Key Terms
Total Voting Rights financial
Treasury financial
Disclosure Guidance and Transparency Rule 5.6.1R regulatory
voting rights financial
Financial Conduct Authority regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What total voting rights did GSK (GSK) report as of 31 March 2026?
Why is GSK (GSK) publishing a total voting rights figure?
AI-generated analysis. How Rhea-AI works. Not financial advice.